Search clinical trials for: LAENNEC

Total 4 results

Green Cross Wellbeing
Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Recruiting

Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome (PAIN)

Shoulder Impingement Syndrome

Korea, Republic of
Green Cross Wellbeing

Recruiting

Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

Chronic Liver Disease

Korea, Republic of
Ho Cheol Shin, M.D., Ph.D.
Green Cross Corporation; Ajou University School of Medicine; Symyoo

Completed

Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients

Chronic Fatigue Syndrome | Idiopathic Chronic Fatigue

Korea, Republic of
King's College Hospital NHS Trust

Recruiting

Reducing Fasting Time for Breast Milk to 3 Hours

Gastric Residual Volume

United Kingdom

3

Subscribe